EUVIMEDEUVIMED entdecken
Crossref

Experience of the SSK (Social Security Agency) Aegean Maternity Hospital on choriocarcinomas

M Murat İnal, Merih Hanhan, Ö Faruk Demir, Mesut Polat, Şivekar Tinar

The Women's Oncology Review · 2004

DOI: 10.1080/14733400400009111 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Women's Oncology Review, 2004. Verfasst von M Murat İnal und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We tried to evaluate the demographic characteristics, treatment modalities and survival chances of the choriocarcinoma cases diagnosed in our hospital retrospectively. Eleven patients diagnosed with choriocarcinoma and treated in our department between January 1994 and December 2001 were used in this study. Seven cases (63.6%) had pulmonary metastasis when diagnosed and one case (9.1%) had additional vaginal metastasis. First-line chemotherapy was given to nine patients (81.9%) and adjuvant chemotherapy was given to two (18.1%), after primary hysterectomy. Interval hysterectomy was applied after four cures of chemotherapy (Methotrexate 0.4 mg/kg 5 days) to two out of the nine cases who had first-line chemotherapy (18.1%). Two hundred and seventy-four (12.7%) of 2155 genital tumors followed-up in the SSK Aegean Maternity Hospital Oncology Department were gestational trophoblastic diseases (GTD). Eleven cases (18.6%) out of 59 (21.5%) who had been given chemotherapy because of differentiation from GTD to gestational trophoblastic neoplasias (GTN) were diagnosed as choriocarcinoma. Mean age of the cases was 34.1 years (range, 20-51 years), all of the cases were multipara and mean parity number was found to be 2.9. Choriocarcinoma was diagnosed histologically with surgery in five cases (45.4%), with curettage in five cases (45.4%) and with biopsy taken from the vaginal metastasis in one case (9.1%). Choriocarcinoma was observed after molar pregnancy in five cases (45.4%), after term pregnancy in three cases (27.2%), after abortus in one case (9.1%), after revision curettage in one case (9.1%) and after ectopic pregnancy in one case (9.1%). According to the classification of Federation of Gynecologists and Obstetricians (FIGO) in 1991, three of the cases (27.2%) were stage IA, two (18.1%) were stage IIIA, three (27.2%) were stage IIIB and two (18.1%) were stage IIIC. Mean follow-up period was calculated as 41.2 months (range, 2-84 months). Choriocarcinomas can be cured with current chemotherapy regimens and optimal surgery for selected cases in spite of high metastasis probability, especially to the pulmonary system. Consequently, cases can be followed-up and remain disease free for long periods. For choriocarcinomas, sensitivity to chemotherapy and studying with a specific marker like ß-hCG are great advantages for obtaining long-term survival.

Zitieren

APA

İnal, M. M., Hanhan, M., Demir, Ö. F., Polat, M., & Tinar, Ş. (2004). Experience of the SSK (Social Security Agency) Aegean Maternity Hospital on choriocarcinomas. The Women's Oncology Review. https://doi.org/10.1080/14733400400009111

Vancouver

İnal MM, Hanhan M, Demir ÖF, Polat M, Tinar Ş. Experience of the SSK (Social Security Agency) Aegean Maternity Hospital on choriocarcinomas. The Women's Oncology Review. 2004. doi:10.1080/14733400400009111

BibTeX
@article{nal2004,
  author = {İnal, M Murat and Hanhan, Merih and Demir, Ö Faruk and Polat, Mesut and Tinar, Şivekar},
  title = {Experience of the SSK (Social Security Agency) Aegean Maternity Hospital on choriocarcinomas},
  journal = {The Women's Oncology Review},
  year = {2004},
  doi = {10.1080/14733400400009111}
}
Kostenlos starten →